HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our CSR
Commitments
Beyond, Together, Sustainably
As the global market leader in pharmaceutical grade biopolymers for medical use, HTL Biotechnology strives every day to provide its clients with products of impeccable quality, to guarantee the health, safety and wellbeing of its employees, to control the environmental impact of its activities and to innovate ethically and responsibly with its clients, suppliers and other partners.
This corporate project is inseparable from the deployment of a genuine and demanding corporate social responsibility policy, which incorporates a three-pronged strategy at the heart of its business model:
Working responsibly with our clients and partners to protect our environment
- Reduce and control our water consumption
- Control aqueous and atmospheric discharges and prevent risks of air, water and soil pollution
- Reduce our fossil fuel consumption (decarbonation) and our greenhouse gas emissions
- Set up management system to reduce our environmental footprint
- Optimise our supply chain with our suppliers and service provide
Setting an example with our employees
- Improve health and quality of life at work
- Guarantee safety
- Ensure a high-quality social climate through open, respectful and ethical dialogue
- Develop diversity and inclusion, and combat all forms of discrimination
- Strengthen the skills management policy
Acting as responsible corporate citizens in our ecosystem
- Continue to make ethics a priority and an asset in terms of reputation in society as a whole
- Give meaning to our corporate citizenship ambition by establishing local and national partnerships
- Contribute to local development, the economy and employment
- Report on our commitments and initiatives through transparent communication
HTL Biotechnology wants to be responsible for its impact
We are convinced that the CSR, as an approach to ongoing improvement, constitutes a wonderful lever for performance, operational excellence, attractiveness and motivation for talent.
HTL Biotechnology develops ambitious, proactive programmes thanks to an engagingaction plan and robust governance.
We assess and control our risks, and transparently measure and report our nonfinancial performance in accordance with the most demanding standards and certifications.
We are therefore committed to incorporating the principles of social responsibility at the highest level of decisionmaking and at the heart of all our activities.
Reduce greenhouse gas emissions by 30% per kg of Hyaluronic Acid produced by 2026
Reduce COD (Chemical Oxygen Demand) in our aqueous discharges between 2024 and 2028
Reduce water consumption per kg of Hyaluronic acid produced by 20% by 2025
Certification ISO 14001
The management system of HTL is certified to the ISO 14001:2015 Environmental Management System standard.
We use ISO 14001:2015 to manage our environmental responsibilities in line with the environmental pillar of our CSR program.
Ecovadis Gold Rating
Our CSR performance is assessed by EcoVadis, a sustainability and Corporate Social Responsibility (CSR) rating agency.
We are proud to have received the Gold EcoVadis sustainability rating for 2025.
